tirzepatide and bupropion vs GLP-1 for Weight Loss: Efficacy Comparison Comparative ocular outcomes of tirzepatide

For the weight management indication, the general requirement is a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity

metformin 0.5 grams three times a day

With copay assistance provided by this program, the cost of the drug for eligible participants may be as low as $25 for a 1- or 3-month supply

Fractures due to aromatase inhibitor therapy for breast cancer: A real-world analysis of FAERS data in the past 15 years

For example, factors such as diet and exercise habits may change the patients response to the drug

However, Tirzepatide may offer greater results because of its dual mechanism